Centene Corporation $CNC Shares Bought by Ninety One UK Ltd

Ninety One UK Ltd raised its stake in Centene Corporation (NYSE:CNC) by 162.6% in the 4th quarter, HoldingsChannel.com reports. The fund owned 1,720,422 shares of the company’s stock after purchasing an additional 1,065,223 shares during the period. Ninety One UK Ltd’s holdings in Centene were worth $70,795,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. Addison Advisors LLC boosted its stake in Centene by 455.6% in the third quarter. Addison Advisors LLC now owns 739 shares of the company’s stock valued at $26,000 after acquiring an additional 606 shares in the last quarter. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in shares of Centene during the third quarter worth about $27,000. GoalVest Advisory LLC acquired a new stake in shares of Centene during the fourth quarter worth about $37,000. Union Bancaire Privee UBP SA acquired a new stake in shares of Centene during the fourth quarter worth about $37,000. Finally, WPG Advisers LLC boosted its stake in shares of Centene by 44.5% during the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after buying an additional 282 shares during the period. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Price Performance

Shares of NYSE:CNC opened at $38.11 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.87. The company has a market cap of $18.74 billion, a P/E ratio of -2.80, a PEG ratio of 0.86 and a beta of 0.59. Centene Corporation has a 52 week low of $25.08 and a 52 week high of $64.15. The company has a 50-day moving average price of $38.23 and a 200 day moving average price of $39.00.

Centene (NYSE:CNC) last issued its earnings results on Friday, February 6th. The company reported ($1.19) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.22) by $0.03. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The company had revenue of $49.73 billion during the quarter, compared to analysts’ expectations of $48.41 billion. During the same period last year, the company posted $0.80 earnings per share. The firm’s quarterly revenue was up 21.9% compared to the same quarter last year. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Research analysts predict that Centene Corporation will post 6.86 earnings per share for the current year.

Analyst Ratings Changes

CNC has been the subject of several recent research reports. Robert W. Baird increased their target price on shares of Centene from $36.00 to $37.00 and gave the stock a “neutral” rating in a research note on Wednesday. Truist Financial increased their target price on shares of Centene from $47.00 to $49.00 and gave the stock a “buy” rating in a research note on Wednesday, February 25th. Jefferies Financial Group decreased their target price on shares of Centene from $43.00 to $37.00 and set a “hold” rating for the company in a research note on Friday, February 13th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Centene from $32.00 to $39.00 and gave the stock a “hold” rating in a research note on Tuesday, February 10th. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $41.00 price objective on shares of Centene in a research report on Monday, February 9th. Three investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, Centene has a consensus rating of “Hold” and a consensus price target of $41.88.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.